AC Immune SA (ACIU)
USD 1.72
(2.99%)
USD 1.72
(2.99%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -39.8 Million CHF | 29.43% |
| 2022 | -56.4 Million CHF | 9.44% |
| 2021 | -62.28 Million CHF | -41.37% |
| 2020 | -44.05 Million CHF | -172.71% |
| 2019 | 60.59 Million CHF | 263.4% |
| 2018 | -37.08 Million CHF | -198.86% |
| 2017 | -12.4 Million CHF | -384.69% |
| 2016 | -2.56 Million CHF | -111.61% |
| 2015 | 22.04 Million CHF | 55.73% |
| 2014 | 14.15 Million CHF | 265.67% |
| 2013 | -8.54 Million CHF | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -16.45 Million CHF | -8.48% |
| 2024 Q1 | -15.16 Million CHF | -9759.24% |
| 2023 Q2 | -13.68 Million CHF | 1.38% |
| 2023 Q1 | -13.87 Million CHF | 8.34% |
| 2023 Q4 | 157 Thousand CHF | 101.27% |
| 2023 FY | -39.8 Million CHF | 29.43% |
| 2023 Q3 | -12.4 Million CHF | 9.32% |
| 2022 Q4 | -15.13 Million CHF | -44.82% |
| 2022 Q2 | -15.69 Million CHF | -3.76% |
| 2022 Q1 | -15.12 Million CHF | 24.85% |
| 2022 FY | -56.4 Million CHF | 9.44% |
| 2022 Q3 | -10.45 Million CHF | 33.4% |
| 2021 Q4 | -20.12 Million CHF | -33.11% |
| 2021 Q2 | -13.71 Million CHF | -2.86% |
| 2021 Q1 | -13.32 Million CHF | 11.18% |
| 2021 FY | -62.28 Million CHF | -41.37% |
| 2021 Q3 | -15.11 Million CHF | -10.27% |
| 2020 Q4 | -15 Million CHF | -4.25% |
| 2020 FY | -44.05 Million CHF | -172.71% |
| 2020 Q1 | -2.79 Million CHF | 79.43% |
| 2020 Q2 | -11.53 Million CHF | -312.12% |
| 2020 Q3 | -14.39 Million CHF | -24.84% |
| 2019 FY | 60.59 Million CHF | 263.4% |
| 2019 Q2 | -11.18 Million CHF | -117.63% |
| 2019 Q4 | -13.6 Million CHF | -162.01% |
| 2019 Q3 | 21.93 Million CHF | 296.02% |
| 2019 Q1 | 63.45 Million CHF | 691.66% |
| 2018 Q4 | -10.72 Million CHF | -16.05% |
| 2018 Q3 | -9.24 Million CHF | -8.65% |
| 2018 Q2 | -8.5 Million CHF | 1.23% |
| 2018 Q1 | -8.61 Million CHF | -237.42% |
| 2018 FY | -37.08 Million CHF | -198.86% |
| 2017 Q4 | 6.26 Million CHF | 187.99% |
| 2017 Q3 | -7.12 Million CHF | -17.03% |
| 2017 Q1 | -5.44 Million CHF | 3.23% |
| 2017 Q2 | -6.08 Million CHF | -11.69% |
| 2017 FY | -12.4 Million CHF | -384.69% |
| 2016 Q4 | -5.63 Million CHF | 11.52% |
| 2016 FY | -2.56 Million CHF | -111.61% |
| 2016 Q3 | -6.36 Million CHF | -144.44% |
| 2016 Q2 | 14.31 Million CHF | 393.1% |
| 2016 Q1 | -4.88 Million CHF | 9.34% |
| 2015 Q3 | 20.21 Million CHF | 108.18% |
| 2015 Q4 | -5.38 Million CHF | -126.65% |
| 2015 FY | 22.04 Million CHF | 55.73% |
| 2015 Q2 | 9.71 Million CHF | 488.32% |
| 2015 Q1 | -2.5 Million CHF | -111.95% |
| 2014 FY | 14.15 Million CHF | 265.67% |
| 2014 Q4 | 20.92 Million CHF | 675.05% |
| 2014 Q2 | -1.56 Million CHF | 0.0% |
| 2014 Q1 | -1.56 Million CHF | 0.0% |
| 2014 Q3 | -3.63 Million CHF | -132.23% |
| 2013 FY | -8.54 Million CHF | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | 4.884% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 142.023% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 102.622% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -78348.955% |
| Apollomics, Inc. | 127 Thousand USD | 31442.52% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -37567.376% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -172965.217% |
| Bicycle Therapeutics plc | -129.52 Million USD | 69.267% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 5063.217% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 33270.833% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 298.509% |
| Chimerix, Inc. | 324 Thousand USD | 12385.494% |
| CRISPR Therapeutics AG | 240.95 Million USD | 116.52% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 179.922% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 196.18% |
| Fortress Biotech, Inc. | 57.85 Million USD | 168.804% |
| Fortress Biotech, Inc. | 57.85 Million USD | 168.804% |
| Gritstone bio, Inc. | -6.26 Million USD | -535.863% |
| Allakos Inc. | -6.14 Million USD | -548.184% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -4059.352% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 369.062% |
| Cytokinetics, Incorporated | -322.59 Million USD | 87.661% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -22645.714% |
| Innoviva, Inc. | 261.06 Million USD | 115.247% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -348821.809% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1020.952% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -395930.246% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -4418.161% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -9876.19% |
| ImmuCell Corporation | 4.39 Million USD | 1005.424% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 62.492% |
| Incyte Corporation | 3.44 Billion USD | 101.157% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -1389.971% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 20543.433% |
| Mustang Bio, Inc. | -2.22 Million USD | -1688.989% |
| MiMedx Group, Inc. | 266.84 Million USD | 114.917% |
| MEI Pharma, Inc. | 49.32 Million USD | 180.696% |
| MacroGenics, Inc. | 50.52 Million USD | 178.78% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | 636.022% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -460.188% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 236.999% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 128.391% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -128377.826% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -40936.082% |
| NextCure, Inc. | -3.68 Million USD | -980.483% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 1646.426% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 309.027% |
| Onconetix, Inc. | -1.12 Million USD | -3431.426% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -37.41% |
| Opthea Limited | 21.72 Thousand USD | 183364.273% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -3203.648% |
| Psyence Biomedical Ltd. | -240.00 USD | -16585316.667% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -69336.207% |
| Precigen, Inc. | 106 Thousand USD | 37651.887% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 4044.995% |
| Prime Medicine, Inc. | -147.9 Million USD | 73.087% |
| PureTech Health plc | -1.6 Million USD | -2383.157% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -460.792% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.352% |
| Replimune Group, Inc. | -2.65 Million USD | -1399.247% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -158808.539% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 136.262% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -7603.011% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 90.04% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 199.513% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 12.179% |
| Solid Biosciences Inc. | -76.56 Million USD | 48.01% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -331608.333% |
| SciSparc Ltd. | 2.19 Million USD | 1912.614% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -49.116% |
| TG Therapeutics, Inc. | 219.1 Million USD | 118.167% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 1414.998% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -2202.198% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 129.752% |
| UroGen Pharma Ltd. | 73.35 Million USD | 154.266% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1009.205% |
| XOMA Corporation | 3.86 Million USD | 1130.951% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -2765.731% |
| AbCellera Biologics Inc. | 38.02 Million USD | 204.681% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -796000.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 55.487% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -27.713% |
| Precision BioSciences, Inc. | 40.47 Million USD | 198.352% |
| Dyadic International, Inc. | 922.95 Thousand USD | 4412.769% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -26978.231% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 288.999% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 9487.972% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -358.213% |
| IGM Biosciences, Inc. | -211.66 Million USD | 81.194% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -1894.238% |
| Acelyrin, Inc. | -115 Thousand USD | -34513.043% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 1734.702% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 133.239% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -197.99% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 125.715% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 59.472% |
| Senti Biosciences, Inc. | -2.68 Million USD | -1383.6% |
| Mesoblast Limited | -9.81 Million USD | -305.553% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 63.974% |
| ChromaDex Corporation | 50.78 Million USD | 178.387% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 133.04% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 666.458% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 129.427% |
| Novavax, Inc. | 639.93 Million USD | 106.22% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 59.45% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 8.416% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 30719.231% |
| Celcuity Inc. | -142.77 Thousand USD | -27780.117% |
| ContextLogic Inc. | 59 Million USD | 167.466% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 7829.126% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 340.122% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.171% |
| Amarin Corporation plc | 165.54 Million USD | 124.045% |
| AnaptysBio, Inc. | 14.78 Million USD | 369.298% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -6920.282% |
| Aptorum Group Limited | -1.11 Million USD | -3470.954% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 262.795% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 116.535% |
| Ardelyx, Inc. | 106.66 Million USD | 137.319% |
| Celularity Inc. | 6.75 Million USD | 689.267% |
| Omeros Corporation | -69.77 Million USD | 42.956% |
| Humacyte, Inc. | -76.55 Million USD | 48.001% |
| Immunocore Holdings plc | 248.39 Million USD | 116.025% |
| IO Biotech, Inc. | -756 Thousand USD | -5165.212% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -2691.374% |
| Summit Therapeutics Inc. | -2.05 Million USD | -1841.707% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -729.617% |
| Pulmatrix, Inc. | -8.22 Million USD | -384.246% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 90.019% |
| Evogene Ltd. | 1.39 Million USD | 2945.247% |
| CorMedix Inc. | -205.56 Thousand USD | -19263.988% |
| BioLineRx Ltd. | 1.1 Million USD | 3692.509% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 8125.202% |
| Sagimet Biosciences Inc. | 2 Million USD | 2090.25% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 104.563% |
| scPharmaceuticals Inc. | 9.78 Million USD | 506.921% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 42.308% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 108.364% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -348821.809% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -137158.621% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -20960.847% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1082.597% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -7481.905% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -89981.017% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -281.093% |
| Daré Bioscience, Inc. | 2.76 Million USD | 1537.252% |
| bluebird bio, Inc. | -4.03 Million USD | -887.717% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 102.09% |
| DBV Technologies S.A. | 15.72 Million USD | 353.084% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 78.058% |
| Galecto, Inc. | -830 Thousand USD | -4695.783% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -6871.103% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -1.174% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 6636.125% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -27677.196% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 172.878% |
| ADMA Biologics, Inc. | 88.21 Million USD | 145.121% |
| Clene Inc. | 533 Thousand USD | 7568.105% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 2102.264% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -8288.035% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -382640.385% |
| Soligenix, Inc. | 97.31 Thousand USD | 41004.934% |
| Century Therapeutics, Inc. | -10.8 Million USD | -268.258% |
| Kura Oncology, Inc. | -849 Thousand USD | -4588.457% |
| Surrozen, Inc. | -27.23 Million USD | -46.181% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 40.682% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 140.191% |
| Autolus Therapeutics plc | -4.86 Million USD | -717.855% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -23593.452% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 48.704% |
| GRI Bio, Inc. | 10.84 Million USD | 467.171% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 1667.135% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 15.017% |
| INmune Bio, Inc. | 155 Thousand USD | 25780.645% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 164.265% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2542.584% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6038.446% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -525725.627% |
| Jaguar Health, Inc. | 7.72 Million USD | 615.342% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -135873.902% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 10001.741% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 605.717% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -12617.252% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 142.139% |
| Verastem, Inc. | -62 Thousand USD | -64101.613% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -15150.958% |
| Histogen Inc. | 3.76 Million USD | 1156.116% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 7008.443% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 105.848% |
| Surrozen, Inc. | -27.23 Million USD | -46.181% |
| Organovo Holdings, Inc. | -5.38 Million USD | -638.634% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -2010253.535% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 756.153% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -59194.514% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 27401.097% |
| Kronos Bio, Inc. | 1.37 Million USD | 3001.239% |
| Turnstone Biologics Corp. | 16.5 Million USD | 341.155% |
| Synaptogenix, Inc. | -6347.00 USD | -627046.683% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -77949.02% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 236.651% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 124.668% |
| Exelixis, Inc. | 1.75 Billion USD | 102.265% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 64.511% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 111.774% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3492.509% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -33493.269% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 643.933% |
| Insmed Incorporated | 239.63 Million USD | 116.611% |
| MediWound Ltd. | 3.57 Million USD | 1212.493% |
| OmniAb, Inc. | 14.66 Million USD | 371.392% |
| Alector, Inc. | -95.05 Million USD | 58.123% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 131.687% |
| Zai Lab Limited | 170.9 Million USD | 123.291% |
| AlloVir, Inc. | -398 Thousand USD | -9901.256% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 148.616% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -3757.074% |
| Aura Biosciences, Inc. | -1.29 Million USD | -2973.745% |
| Immunic, Inc. | -111 Thousand USD | -35760.36% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 351.072% |
| Veracyte, Inc. | 248.14 Million USD | 116.041% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.43% |
| FibroGen, Inc. | 128.9 Million USD | 130.88% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 112.69% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -7057524.113% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -241.179% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 10332.648% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 111.202% |
| Fortrea Holdings Inc. | 424 Million USD | 109.388% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 53.805% |
| XBiotech Inc. | -1.74 Million USD | -2182.397% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -3492.509% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -5894.729% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 14.344% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 47.302% |
| Agenus Inc. | 139.61 Million USD | 128.511% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 154.228% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 336.892% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 110.232% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 19.824% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 112.182% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -251.515% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 58.943% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 737229.63% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -59464.248% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -22666.139% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -10543.048% |
| Ainos, Inc. | -253.73 Thousand USD | -15587.751% |
| Pluri Inc. | 322 Thousand USD | 12461.801% |
| Prothena Corporation plc | -129.2 Million USD | 69.191% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 178.941% |
| Rallybio Corporation | -150 Thousand USD | -26436.667% |
| Kodiak Sciences Inc. | -25.94 Million USD | -53.409% |
| Cue Biopharma, Inc. | -32.6 Million USD | -22.075% |
| MeiraGTx Holdings plc | 287 Thousand USD | 13969.338% |
| Annexon, Inc. | -3.26 Million USD | -1118.396% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 4.629% |
| Moderna, Inc. | 2.15 Billion USD | 101.847% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -162.41% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 163.808% |
| Blueprint Medicines Corporation | 236.58 Million USD | 116.825% |
| Immix Biopharma, Inc. | -5468.00 USD | -727862.692% |
| CalciMedica, Inc. | -58 Thousand USD | -68529.31% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -539.746% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -1299.613% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 138.238% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -28.965% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -3302.137% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 1534.112% |
| Nutriband Inc. | 862.1 Thousand USD | 4717.187% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -11573.021% |
| Vor Biopharma Inc. | -3.49 Million USD | -1039.891% |
| Roivant Sciences Ltd. | 109.23 Million USD | 136.44% |
| Alkermes plc | 1.37 Billion USD | 102.896% |
| ProKidney Corp. | -3.16 Million USD | -1156.074% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 9.353% |
| Arcellx, Inc. | 108.27 Million USD | 136.762% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 680.502% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 49.403% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -120521.212% |
| Atai Life Sciences N.V. | -5000.00 USD | -796000.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -32564.801% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -41363.542% |
| MediciNova, Inc. | 979.7 Thousand USD | 4162.958% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 52.792% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -41997.192% |
| GeoVax Labs, Inc. | -20.72 Million USD | -92.102% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 116.278% |
| Biomea Fusion, Inc. | -4.2 Million USD | -847.512% |
| RenovoRx, Inc. | - USD | Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -12740.323% |
| Geron Corporation | -123.5 Million USD | 67.77% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -796000.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 47.881% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -1517.432% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 118.624% |
| Royalty Pharma plc | 1.79 Billion USD | 102.219% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -4130.074% |
| Imunon, Inc. | -720 Thousand USD | -5428.434% |
| BioAtla, Inc. | -103.73 Million USD | 61.627% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 83.607% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -12699.035% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 64.273% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -4093.646% |
| 89bio, Inc. | -273 Thousand USD | -14480.586% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 43.205% |
| aTyr Pharma, Inc. | -2.38 Million USD | -1566.876% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 419.462% |
| Viridian Therapeutics, Inc. | -1 Million USD | -3848.909% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 306192407.692% |
| Akari Therapeutics, Plc | -4000.00 USD | -995025.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 106.25% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 3657.194% |
| Liquidia Corporation | 14.6 Million USD | 372.637% |
| Entera Bio Ltd. | -56 Thousand USD | -70980.357% |
| GH Research PLC | -315 Thousand USD | -12536.508% |
| Vericel Corporation | 135.57 Million USD | 129.36% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 28.355% |
| Xencor, Inc. | -85.26 Million USD | 53.313% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -17913.187% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -6038.446% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -3875.586% |
| Vaxcyte, Inc. | -75 Million USD | 46.927% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 76.238% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 122.382% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 20543.433% |
| Portage Biotech Inc. | -54 Thousand USD | -73612.963% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -41997.192% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -10458.355% |
| OncoCyte Corporation | 413 Thousand USD | 9738.015% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -885439.488% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -17930080.18% |
| Purple Biotech Ltd. | -196 Thousand USD | -20208.673% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -10347.507% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -81.039% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 158.429% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 543.856% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -31242.52% |
| United Therapeutics Corporation | 2.07 Billion USD | 101.923% |
| HilleVax, Inc. | -2.15 Million USD | -1746.243% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 60170.325% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -909.754% |
| Pharming Group N.V. | 220.1 Million USD | 118.085% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -265195.921% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -5858.832% |
| Pyxis Oncology, Inc. | -2 Million USD | -1890.25% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -530197.782% |
| Savara Inc. | -44.26 Million USD | 10.07% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -48442.683% |
| Curis, Inc. | 9.81 Million USD | 505.718% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -31798.099% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -17358.333% |
| BeiGene, Ltd. | 2.07 Billion USD | 101.915% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 170.218% |
| Erasca, Inc. | -3.73 Million USD | -966.586% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -140962.442% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -140962.442% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -4250.273% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 597.19% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -7326.306% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 64.181% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1009.392% |
| Adicet Bio, Inc. | -6.09 Million USD | -552.755% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 110.995% |
| Aditxt, Inc. | -111.66 Thousand USD | -35548.397% |
| Adagene Inc. | 18.11 Million USD | 319.778% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 8256.762% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 125.219% |
| Compugen Ltd. | 31.45 Million USD | 226.546% |
| Generation Bio Co. | -73.91 Million USD | 46.145% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -9008.696% |
| Invivyd, Inc. | -2.02 Million USD | -1862.771% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 86.769% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -38381.989% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 141.305% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 140.498% |
| Instil Bio, Inc. | -4.75 Million USD | -736.943% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 265.103% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 3608.347% |
| GeoVax Labs, Inc. | -20.72 Million USD | -92.102% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -20384.674% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -4661.364% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 147.719% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 54543.867% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 174.875% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 77.016% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -11176.204% |
| Cingulate Inc. | -582.91 Thousand USD | -6728.576% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -128303.226% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -102.066% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -3928.846% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -70548.894% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 25.828% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -13531.849% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -7453.131% |
| ImmunityBio, Inc. | -17.89 Million USD | -122.499% |
| Korro Bio, Inc. | -3.63 Million USD | -996.556% |
| Kineta, Inc. | 5.43 Million USD | 832.652% |
| BioVie Inc. | -229.37 Thousand USD | -17253.527% |
| Codexis, Inc. | 57.33 Million USD | 169.427% |
| Celularity Inc. | 6.75 Million USD | 689.267% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -33349.58% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1091.901% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 78781.558% |
| Cibus, Inc. | 1.42 Million USD | 2899.226% |
| IN8bio, Inc. | -2.5 Million USD | -1491.563% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -1847.407% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 6319.531% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 105.113% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 123.015% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | -101964.103% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -1995.0% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -22.973% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 150.256% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -88.186% |
| Moolec Science SA | -143.3 Thousand USD | -27676.421% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 5.938% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 1310.983% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 43.209% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -2006.085% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1101921.041% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 17302.484% |
| Humacyte, Inc. | -76.55 Million USD | 48.001% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -3066.667% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -4593.986% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -32261.789% |
| Notable Labs, Ltd. | 113 Thousand USD | 35325.664% |
| Immunovant, Inc. | -231 Thousand USD | -17131.602% |
| Quantum-Si incorporated | 488 Thousand USD | 8256.762% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -132583.333% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 2237.755% |
| Acasti Pharma Inc. | -11 Thousand USD | -361763.636% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -19353.418% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -1932.942% |
| PepGen Inc. | -1.18 Million USD | -3261.909% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -73.844% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -48099.993% |
| Immuneering Corporation | -764.13 Thousand USD | -5109.138% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Belite Bio, Inc | -399 Thousand USD | -9876.19% |
| XOMA Corporation | 3.86 Million USD | 1130.951% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -98.667% |
| Bionomics Limited | -434.44 Thousand USD | -9062.18% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3606.238% |
| uniQure N.V. | 2.21 Million USD | 1897.065% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 56.766% |
| Forte Biosciences, Inc. | -9000.00 USD | -442177.778% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -4667.066% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -9008.696% |
| Altimmune, Inc. | -65.37 Million USD | 39.111% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -1553.718% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -3606.238% |
| Peak Bio, Inc. | 367.76 Thousand USD | 10923.37% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 262.363% |
| Benitec Biopharma Inc. | 108 Thousand USD | 36956.481% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -50932.051% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -3208.811% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -2084.687% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -3208.811% |
| argenx SE | 1.1 Billion USD | 103.591% |
| Immunome, Inc. | -8.9 Million USD | -346.896% |
| Verona Pharma plc | -679.62 Thousand USD | -5756.915% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -22645.714% |
| Shattuck Labs, Inc. | -2.38 Million USD | -1568.973% |
| CervoMed Inc. | -1.29 Million USD | -2977.008% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -733.264% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 1710.886% |
| Moolec Science SA | -143.3 Thousand USD | -27676.421% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -9655.41% |
| Design Therapeutics, Inc. | -537 Thousand USD | -7312.477% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -9222.014% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 1954.846% |
| Achilles Therapeutics plc | -4.73 Million USD | -741.318% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 12.609% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 92669.767% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -4742.457% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -302415.58% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -120521.212% |
| Beam Therapeutics Inc. | -59.67 Million USD | 33.294% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 128.568% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 284.753% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -13302.357% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -888.444% |
| NeurAxis, Inc. | 2.15 Million USD | 1945.64% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -316.109% |
| Lumos Pharma, Inc. | 2 Million USD | 2083.308% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 225.731% |
| Palisade Bio, Inc. | 246 Thousand USD | 16280.894% |
| Nutriband Inc. | 862.1 Thousand USD | 4717.187% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 382.706% |
| Neurogene Inc. | -3.26 Million USD | -1120.264% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -72272.727% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -978.142% |
| Athira Pharma, Inc. | -969 Thousand USD | -4007.843% |
| HCW Biologics Inc. | -574.82 Thousand USD | -6824.728% |
| XOMA Corporation | 3.86 Million USD | 1130.951% |
| Nektar Therapeutics | 53.47 Million USD | 174.432% |
| Arvinas, Inc. | 71.8 Million USD | 155.439% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 52.307% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 36.591% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -12261.801% |
| Rezolute, Inc. | -36 Thousand USD | -110469.444% |
| Clene Inc. | 533 Thousand USD | 7568.105% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -3099977.882% |
| BeyondSpring Inc. | 1.75 Million USD | 2373.272% |
| Synlogic, Inc. | -1.92 Million USD | -1968.867% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -107481.081% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -528.632% |
| Peak Bio, Inc. | 367.76 Thousand USD | 10923.37% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -109.909% |
| Krystal Biotech, Inc. | 47.6 Million USD | 183.615% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 128.212% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 892.139% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -1437.336% |
| MannKind Corporation | 136.19 Million USD | 129.227% |
| Ikena Oncology, Inc. | -50.49 Million USD | 21.166% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 136.581% |
| Gossamer Bio, Inc. | -4.38 Million USD | -807.754% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -15695.635% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -796000.0% |
| Legend Biotech Corporation | 140.92 Million USD | 128.245% |
| Mural Oncology plc | -2.56 Million USD | -1450.643% |
| Disc Medicine, Inc. | -100 Thousand USD | -39705.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 291.794% |
| REGENXBIO Inc. | 53.02 Million USD | 175.063% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -643.053% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -20591.358% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -2198.21% |
| Vaxart, Inc. | -60.76 Million USD | 34.491% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -15047.652% |
| Cellectis S.A. | 18 Thousand USD | 221238.889% |
| Longeveron Inc. | 221 Thousand USD | 18111.312% |
| Repare Therapeutics Inc. | -80.07 Million USD | 50.287% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 103.642% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -2976.121% |
| Revolution Medicines, Inc. | -399.66 Million USD | 90.04% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -113628.571% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 81334.694% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.462% |
| Denali Therapeutics Inc. | -93.34 Million USD | 57.357% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -158808.539% |
| Veru Inc. | 7.56 Million USD | 626.109% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -26260.927% |
| Cingulate Inc. | -582.91 Thousand USD | -6728.576% |
| Passage Bio, Inc. | -3.72 Million USD | -969.739% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -330396.513% |
| Exicure, Inc. | -1.42 Million USD | -2697.259% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -10292.95% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 1572.623% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -7664.178% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -26506.375% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 32.769% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 10280.307% |
| OmniAb, Inc. | 14.66 Million USD | 371.392% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 299.095% |
| Lipocine Inc. | -2.85 Million USD | -1296.266% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -2059.794% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -597.721% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -2542.584% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 152.851% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -61138.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 147.221% |
| Ocugen, Inc. | -33.53 Million USD | -18.69% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1158.855% |
| Q32 Bio Inc. | 578 Thousand USD | 6986.678% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -14920.755% |
| Alumis Inc. Common Stock | -1.28 Million USD | -3000.078% |
| Equillium, Inc. | 35.95 Million USD | 210.699% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -2231.869% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 8050.204% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -962768.892% |
| Dominari Holdings Inc. | 2.03 Million USD | 2052.182% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -21595.527% |
| vTv Therapeutics Inc. | -13.59 Million USD | -192.791% |
| Bio-Techne Corporation | 773.07 Million USD | 105.149% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 329.834% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 108.639% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -3305.047% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -65.992% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 440.301% |
| Nkarta, Inc. | -5.86 Million USD | -578.225% |
| BioCardia, Inc. | -7.24 Million USD | -449.11% |
| Iterum Therapeutics plc | -1.75 Million USD | -2174.571% |